Tobacco Institute
[Information Regarding Dr. Gio Batta Gori]
Fields
- Alias
- TIMN0431078 - TIMN0431101
- Type
- REPORT
- Characteristic
- CONFIDENTIAL
- Site
- CB1588, TI Storage Box 5924
- Date Loaded
- 05 Jun 1998
- Request
- Mn1-59
- Box
- 147
- Litigation
- Minnesota AG
- UCSF Legacy ID
- exy52f00
Document Images
DR. GIO BAT'I'A GORI
Director, Health Policy Center. 0. irrently heads a program of basic and applied studies for
an independent a.ase.ument of health hazards and risks, of costs and benefits of regul8tion,
and the formulation oi' palic.y Hlternatives compatible with health and safety, and with a
sound economy.
PROFE3SIONAL PROFILE
Broad experience in toxicology, cpidemiology, carcinogcncais and management. Exerted
national leadership In r,arcinegenesis research, methods and priorities of carcinogen tcating,
epidcminlogy, smokfng and health, nutrition, crione depiction and ultraviolet radiation, cost
and benefit analysis of prevention policies, safety and carcinogen regulation. Played key
rules in the succcasful passage of the 1970 Cancer Act find subsequent appropriations.
PIHnned and managed research and intervention programs of national and international
swpe, rstablishing consensus priorities in cancer causation, prevention and wntrol, and
patient manHgement. First hand imderstanding of federal research cind regulatory agen-
c.-ins, the budgetary and appropriations process, Congress and legislative operations, the
diversity of motivation in private enterprise, acadcmia, advocacy groups, and a pluralistic
soc.~ioeconrnnic reality. Direct multilingual contacts with parallel issues and ofganizations in
F:urope. Numerous appearances at congressional hearings. Congressional contacts and
famif iarity with the ltay and scfentifiC media.
1
TIMN 431079
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION

L7DUCATJON
Doctor of i3iologieal Sciences, University of Camerino (Italy), 1956. Financial Analysis
f'rogrAm, Dun and Bradstreet School of Bu.winess,1965. Program for Senior Managers in
Government, Harvard Business School,19'17. Master of Public Health, Jobna Hopkins
Univeraity,1979.
POSITIONS HELD
From 19RO to 1987, Dr. Gori was Dlrector of The Franklin Institute Policy Analysis Center.
Before, he held several pasitions at the National Cunccr Institute (1968-1980), most recent-
ly as Deputy Director of the 17ivtsion of Cancer Cause and Prevention (1972 80), with
simultaneous re:pnnsibditiea ax Acting Amxziate Direwtor, Cardnogrnesis Program (1976-
1978); Director, Diet, Nutrition and Cancer Program (1973-1980); Associate Scientific
Director for Program, DCXT (1968-1972); Directar, Smoking and Health Program (1968-
1980).
Was previously Director of the Biological Rcaearch Laboratory at Litton Systems, Inc.,
Bethesda, Maryland, (1967-1968); Head of the Virology, Immunology, and Toxicology
Sections at Melpar, Inc., raila C:hurch, Virginia, (1965-1967); Assistant to the President for
Technical Affairs, Director of Quality C.onttvl, and Director of Production at Microbioingi-
a! Aasociates, Inc., Bethesda, Maryland, (1962-1965).
Larliar research positions were Associatc, Wistar Institute, Philadelphia, Pennsylvania;
Aswociate Director, Iatltuto 5ciavo, Siona, Italy; Research Associate, Virus Research
l.aboratory, University of Pittsburgh, Pennsylvania; and Associate, Mierobiology and Virus
Department, Istituto Superiore di Sfurita`, Rome, Italy.
SQiTORIAI. AGTINPIISS
Nutrition and Cancer, An Internataonal Journal - Editor
Journal of Toaicology and Environmental Heahh - Bditorial Board
Regulatory Toricology and Pharmacology - Editorial Board
2
TIMN 431080
CONFIDENTIAL:
MINNESOTA TOBAC C O LITIGATION

PROFESSIONAL AFFILIATIONS
Diplomxte: The Acaderrry of Tcnricological Seiencx3
Society uf Toxic:ology: former member, Technicul Cc:mmittre, Regulatory Affairs
and Legislative Asaista.nr.G Committee
Tnxicology Forum
American Society forParettteral and Enteral Nutrition
American Public Health As9ociation
American Association for Advancement of Science
International Society of Reguiatory Toxicalogy and Pharmacology :
Ocxird Member and Vice President
ADDRESSES
Office : 6704 Barr Road, Bethesda, MD, 20816
3t111229-4277. Fax 301f229-4278.
Home : 6303 Pyle Road, Bethesda, MD, 20817
301/229-0450.
3
TIMN 431081
CONNh'II)iENTIALe
MINNESOTA TOBACCO LITIGATION

AWARDS
Public Health Service Superior Service Award - 1976
"For contributions to broad-ranging programs in cancer causations
in both national and international operations and leadership and
management of the Smoking and Health Program."
HONORS
Chairman
Conference, New Techniques in Virus Production, Annual
Meeting,Society for Industrial Microbiology, Burlington, Vermont,
August 1970.
Tobacco Working Group, 1970-1974 (NCI).
Tobacco Segment, Carcinogenesis Area, NCI, 1970-1974.
Liaison Subcommittee, Joint Committee on Smoking and Health (HEW,
AMA, CTR, HEW Secretary Sponsor), 1971-1973.
Study Group for Reverse Transcriptase Antagonists (NCI), 1971-
1972.
Pharmocological and Clinicar Approaches in Smoking Working Group,
1971-1973 (NCI).
Session on Smoking and Lung Cancer, Conference on Lung Carcinoma,
National Cancer Institute, Bethesda, Maryland, March 1972.
Ultraviolet Radiation and Skin Cancer Committee (HEW-DOT), 1972-
1974.
Dietary Factors and Cancer of the Large Bowel, Conference on
Nutrition in the Causation of Cancer, American Cancer Society and
the National Cancer Institute, Key Biscayne, Florida, March 1975.
Human Health Effects Group, Biologic Assessment Program of
Inadvertent Modification of the Stratosphere, Environmental
Protection Agency, Washington, DC, 1976.
4 TIMN 431082
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION

Conference on Nutrition and Cancer Therapy, American Cancer
Society and the National Cancer Institute, Key Biscayne, Florida,
November 1976.
Symposium on Bioassay Models and Inhalation Toxicology, Tampa,
Florida, 1976.
Organizing Committee, National Conference on Nutrition and
Cancer, American Cancer Society, Seattle, Washington, 1978.
Interagency Committee for Stratospheric Ozone Protection - EPA -
Health Effects Group, 1979.
Program Committee, International Society of Regulatory
Pharmacology and Toxicology, 1986-89.
Executive Secretary
Tobacco Working Group, 1969-1970.
Cancer Cause and Prevention Advisory Committee, NCI, 1970-1974.
Smoking and Health Committee, National Cancer Advisory Board,
1973.
Diet, Nutrition and Cancer Program Advisory Committee, NCI, 1975-
1978.
Cancer and Nutrition Scientific Review Committee, NCI, 1976-1978.
Diet and Cancer Scientific Review Committee, NCI, 1976-1978.
Carcinogenesis Scientific Advisory Committee, NCI, 1976-1978.
Member
Committee for the Definition of Hazardous Substances in Tobacco
Smoke, National Clearinghouse for Smoking and Health, Rockville,
Maryland, 1970.
5 TIMN 431083
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION

Advisory Group for Pesticide Residues in Tobacco, USDA,
Washington, DC, 1971.
Organizing Committee, XI International Cancer Congress, 1971-
1974.
Committee on Tobacco and Cancer, American Cancer Society, 1971-
1978.
IARC/WHO Committee on Evaluation of Carcinogenic Risks of
Chemicals to Man, 1972-1978.
Organizing Committee, III International Conference on Smoking and
Health, 1973-1975.
Workshop on Approaches to Assess the Significance of Experimental
Chemical Carcinogenesis Data for Man, Brussels, Belgium, 1973.
Molecular Control Working Group, NCI, 1973-1976.
Review Task Force, ARS-USDA Activities in Tobacco Research, 1973-
1980.
Kentucky Tobacco and Health Research Board, Louisville, Kentucky,
1975-1978.
Nutrition Coordinating Committee, NIH, 1975.
Task Force on Tobacco and Cancer, American Cancer Society, 1975-
1976.
Committee on Prevention, Institute of Medicine, 1975-1979.
Board of Scientific Advisors, American Society for Enteral and
Parenteral Nutrition, 1977-1979.
Organizing Committee, NIH Conference on Nutrition, 1978.
Internationa 1 Union Nutritional Sciences. Workshop, Committee on
Nutrition and Cancer, Cambridge, England,_1980.
Task Force on the Delaney Clause, Council for Agricultural
Science and Technology, Washington, DC, 1980.
Technical Committee, Society of Toxicology, 1980-1981.
American Council on Science and Health, Steering Committee, 1981.
CONFIDENTIAL: 6 TIMN 431084
MINNESOTA TOBACCO LITIGATION

Legislative Committee, Society of Toxicology, 1982-1983.
Regulatory Affairs and Legislative Assistance Committee, Society
of Toxicology, 1983-1984.
Scientific Committee of the 3rd Annual Symposium of the European
Organization of Cooperation in Cancer Prevention Studies, 1983-
1985.
Invited Speaker, selected meetings
Planning and Management of Research, Carlo Erba Foundation and
National Tumor Institute, Milan and Rome, 1970.
Continuous Cultivation of Viruses, Istituto Superiore di Sanita,
Rome, 1970.
Continuous Cultivation of Viruses, Society for Industrial
Microbiology, Annual Meeting, Burlington, Vermont, 1970.
Research for a Less Hazardous Cigarette, Second International
Smoking and Health Conference, London, England, 1971.
Planning and Management of Scientific Research Programs, Grants
Associates Seminars, National Institutes of Health, Bethesda,
Maryland, 1971.
Smoking and Lung Cancer, Conference on Carcinoma of the Lung,
National Cancer Institute, Bethesda, Maryland, 1972.
Ranking of Suspicion of Hazard of Environmental Contaminants,
Advisory Committee, Toxicology Information Program, National
Library of Medicine, Bethesda, Maryland, 1972.
Ranking of Environmental Contaminants for Bioassay Priority,
Second International Symposium on Cancer Detection Prevention,
Bologna, Italy, 1973.
Search for Less Hazardous Cigarette, XI International Cancer
Congress, Florence, Italy, 1974.
Prevention of Smoking Related Disease -Seminar- Roswell Park
Memorial Institute, Buffalo, New York, 1974.
7
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION
TIMN 431085

Smoking Cessation Clinics, National Cancer Institute of Brazil,
Rio de Janeiro, Brazil, 1975.
Tobacco Particulate Matter, Third World Conference on Smoking and
Health, New York, New York, 1975.
Ranking of Environmental Contaminants for Bioassay Priority,
Workshop on the Investigation of the Carcinogenic Burden by Air
Pollution in Man, Hannover, Germany, 1975.
A Program for Control of Smoking Related Diseases--Seminar and
Consulting--The Government of the Philippines, Manila, 1975.
Nutrition and Cancer, XI International Congress on Nutrition,
Kyoto, Japan, 1975.
Dietary Factors and Cancer of the Large Bowel Conference on
Nutrition in the Causation of Cancer, American Cancer Society and
the National Cancer Institute, Key Biscayne, Florida, 1975.
Less Hazardous Cigarettes, 3rd International Symposium on
Detection and Prevention of Cancer, New York, New York, 1976.
Diet, Nutrition and Cancer Program, Candlelighters Meeting,
Washington, DC, 1976.
Col loquium on Nutrition and Cancer, Oak Ridge National
Laboratories, 1976.
Nutrition and Cancer -Seminar- Fred Hutchinson Cancer Center,
Seattle, Washington, 1976.
Diet, Nutrition and Cancer, Food Research Institute, Madison,
Wisconsin, 1976.
Nutrition as a Possible Cause of Cancer, Massachusetts Dietetic
Association, Framingham, Massachusetts, 1976.
Cancer and Diet, American Dietetic Association, Boston,
Massachusetts, 1976.
UICC Workshop on Lung Cancer, Geneva, Switzerland, 1976.
Food and Nutrition Liaison Committee Meeting, Naples, Florida,
1976.
Nutrition and Cancer Symposium, Columbia University, New York,
New York, 1976.
CONFIDENTIAL: 8 TIMN 431086
MINNESOTA TOBACCO LITIGATION

Nutrition and Cancer Therapy, American Cancer Society, New York,
1976.
Prevention of Smoking Related Diseases, Institute of Medicine,
National Academy of Sciences, 1977.
American Dietetic Association Legislative Workshop, Washington,
DC, 1977.
Diet, Nutrition and Cancer, Brookhaven National Laboratory,
Upton, New York, 1977.
Nutrition and Cancer, Foundation Curie, Paris, France, 1977.
Nutrition and Cancer, 18th Annual Meeting of the American College
of Nutrition, Houston, Texas, 1977.
Nutritional Variables in Perinatal Carcinogenesis, 6th Perugia
Quadrennial International Conference on Cancer, Perugia, Italy,
1977.
Conference on Commonalities in Substance Abuse and Habitual
Behavior, Airlie House, Warrenton, Virginia, 1977.
Conference on Ultraviolet Carcinogens, Airlie House, Warrenton,
Virginia, 1977.
Reducing the Hazard and Addictive Properties of Cigarettes,
Alcoholism and Drug Abuse Institute's Summer Conference, Seattle,
Washington,1977.
Nutrition and Cancer, International Conference on Cancer and
Environment, Montreal, Canada, 1977.
Symposium on Smoking and Health, University of Munich, West
Germany, 1977.
Symposium on Smoking and Health, UNAMSI, Milan, Italy, 1977.
Prevention Alternatives to Raising Disease Costs, American Health
Foundation, New York, 1977.
Consulting Party on Less Hazardous Cigarettes, Canadian
Government, Ottawa, January 1978.
Advisory Symposium in Nutrition, Kellogg Foundation, Battle
Creek, Michigan, April 1978.
9 TIMN 431087
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION

Conference on Health Economics, Hudson Institute, Washington, DC,
May 1978.
International Symposium on the Chemical Toxicology of Foods,
Milan, Italy, 1978.
Drug Dependence Conference, Baltimore, 1978.
ACS-NCI Conference on Nutrition and Cancer, Seattle, Washington,
August 1978.
Workshop on Carbon Monoxide Toxicology, Ministry of Health,
Berlin, West Germany, 1978.
Governor's Conference on Nutrition, Minneapolis, Minnesota,
November 1978.
Symposium on Environmental Determinants of Cancer, New York
University, New York, January 1979.
Smoking and Health Program Conference, Savannah, Georgia, 1979.
Smoking and Health Conference, Celle, West Germany, April 1979.
Nutrition and Cancer, Meeting of the American Society of Clinical
Oncology, New Orleans, May 1979.
Institute of Food Technologists Meeting, St. Louis, Missouri,
June 1979.
Fourth International Symposium on the Prevention and Detection of
Cancer, London, England, 1980.
Nutrient Intake and Carcinogenesis, Western Maryland Nutrition
Symposium for Health Care Professionals, Frostburg State College,
Maryland, November 1980.
Environment and Cancer, Maryland Cancer Program, Pathobiology and
Management of Neoplastic Diseases course, University of Maryland,
Baltimore, Maryland, November 1980.
James M. Perelman Visiting Professor in Oncology, Akron General
Medical Center, Akron, Ohio, November 1980.
Visiting Lecturer, Kellogg National Fellows, Pontiac, Michigan,
November 1980.
TIMN 431088
CONFIDENTIAL: 10
MINNESOTA T®BA.C C ® LITIGATION

International Conference on the Environmental Aspects of Cancer,
American Health Foundation, New York, New York, February 1982.
Association of Food and Drug Officials/Association of Official
Analytical Chemists Workshop, New Orleans, Louisiana, April 1982.
Annual Meeting of the American College of Neuropsychpharmacology,
San Juan, Puerto Rico, December 1982.
Cancer hazards, risks and thresholds: an Assessment. Cancer and
the Environment Symposium. International Center for Environmental
Health Sciences. New York, 1983.
Cancer and Dietary Connections...If Any, 1983 Nutrition Press
Symposium, Texas Cattle Feeders Association, Phoenix, Arizona,
March 1983.
Dietary Factors and Carcinogenesis, Sixth World Congress of Food
Science and Technology, Dublin, Ireland, September 1983.
Side-Stream Smoke: Fact and Fiction, Passive Smoking Workshop,
American Society of Heating, Refrigerating and Air-Conditioning
Engineers, Inc., Atlanta, Georgia, February 1984.
Panel Chairman: De minimis and drinking water standards.
International Society for Regulatory Pharmacology and Toxicology.
Annual Meeting. Washington, DC, 1987.
Epidemiology and the concept of causation in multifactorial
diseases. International Society for Regulatory Pharmacology and
Toxicology. Annual Meeting, Baltimore, 1988.
Numerous Television and Radio Interviews on the Subjects of
Cancer Prevention, Smoking and Health and Nutrition ano Cancer.
Several Appearances at Congressional Hearings on Ultraviolet
Radiation and Cancer, Smoking and Health and Nutrition.
11
CONFIDENTIAL:
MINNBSOTA TOBACCO LITIGATION
,VgMS 431089

BIBLIOGR.APHY
Penso, G., V. Ortali and G.B. Gori: Contribution to the
morphological and biochemical study on halophilic bacteria.
Symposium on Brines, Cambridge, England, pp. 21-28, 1957.
Lelli, G., D. Balducci and G.B. Gori: Contribution to the
morphological study of in vitro cultivated cells. (Italian).
Rend. Istit. Sup. Sanita 20:1113-1125, 1957.
Gori, G.B.: Automatic trypsinization of animal tissues.
(Italian). Rend. Istit. Sup. Sanita 21:850-865, 1958.
Frank, M. and G.B. Gori: Automatic control of continuous
biological processes through medium turbidity. (Italian). La
Ricerca Scientifica 28:2023-2030, 1959.
Felici, A., D. Balducci and G.B. Gori: Annual Proceedings of the
Research Activities of the Virus Department (1957). (Italian).
Rend. Istit. Sup. Sanita 22:345-355, 1959.
Gori, G.B.: Soil algae and their altitudinal distribution on the
Sibillini Appennins. (Italian). Ph.D. Thesis, 1956. Rend.
Istit. Sci. Univ. Camerino 1:113-125, 1960.
Felici, A., D. Balducci and G.B. Gori: Annual Proceedings of the
Research Activities of the Virus Department (1958). (Italian).
Rend. Istit. Sup. Sanita 23:503-514, 1960.
Salk, J.E. and G.B. Gori: Theoretical, experimental and
practical considerations in the use of formaldehyde for the
inactivation of poliovirus. Ann. NY Acad. Sci. 83:609-637, 1960.
Balducci, D., G. Andreoni and G.B. Gori: Cytopathic index: A
new method for quantitative evaluation of tissue culture
infectivity of different virus strains. J. Bacteriology 79:379-
383, 1960.
Gori, G.B.: The Lysostat: Apparatus for the dynamic
investigation and growth of virus-carrying or sterile cell
populations. Ann. Sclavo 2:529-533, 1960.
CONFIDENTIAL: 12 ,-VIM.1S 431090
MINNESOTA TOBACCO LITIGATION

Gori, G.B.: Trypsinization of animal tissues for cell culture:
theoretical considerations and automatic apparatus. Applied
Microbiology 12:115-121, 1964.
Gori, G.B. and D.Y. Lee: A method for the eradication of
Mycoplasma infections in cell cultures. Proc. Soc. Exptl. Biol.
Med. 117:918-921, 1964.
Gori, G.B.: Chemostatic concentrated culture of heteroploid
mammalian cell suspensions in dialyzing fermentors. I.
Experimental evidence and theoretical considerations. Applied
Microbiology 13:93-98, 1965.
Gori, G.B.: The Lysostat: Single and multistage continuous
cultivation of viruses in cell suspensions. Theoretical and
experimental evidence. Applied Microbiology 13:909-917, 1965.
Gori, G.B.: Medium pollution rates in cell cultures. J. Nat.
Cancer Inst. 44:275-281, 1970.
Gori, G.B.: The continuous cultivation of viruses. In:
Developments in Industrial Microbiology 11:20-31, 1970. American
Institute of Biological Sciences, Washington, DC.
Gori, G.B.: Research in Smoking and Health at the National
Cancer Institute. J. Nat. Cancer Inst. 48:1759-1762, 1972.
Gori, G.B.: Smoking and cancer: research in etiology and
prevention at the National Cancer Institute. Cancer 30:1340-
1343, 1972.
Tso, T.C. and G.B. Gori: Effect of tobacco characteristics on
cigarette smoke composition. In: The Chemistry of Tobacco and
Tobacco Smoke. New York, Plenum Publishing Corp., pp. 51-64,
1972.
Gargus, J.L., J.J. Gart, R.P. Kwapien and G.B. Gori: Replicate
control values in large scale mouse dermal bioassays of tobacco
smoke condensates. Toxicology and Applied Pharmacology 25:478,
1973.
Battista, S.P., M.R. Guerin, G.B. Gori and C.J. Kensler: A new
system for quantitatively exposing laboratory animals by direct
inhalation. Archives of Environmental Health 27:376-382, 1973.
TIMN 431091
CONFIDENTIAL: 13
MINNESOTA TOBACCO LITIGATION

Stoner, G.D., M.B. Shimkin, A.J. Kniazeff, J.H. Weisburger, E.K.
Weisburger and G.B. Gori: Test for carcinogenicity of food
additives and chemotherapeutic agents by the pulmonary tumor
response in strain A mice. Cancer Research 33:3069-3085, 1973.
Hoffmann, D., K.D. Brunnemann, G.B. Gori and E.L. Wynder: On the
carcinogenicity of marijuana smoke. In V.C. Runeckles (ed.),
Recent Advances in Phytochemistry, Vol. 9, Plenum Publishing
Corp., New York, 1975.
Tso, T.C. and G.B. Gor i: Leaf qua l ity and usabi l ity -
theoretical model 1. In Chemical Marketing and Economics.
American Chemical Society, Philadelphia, Pennsylvania, p. 258-
275, 1975.
Tso, T.C. and G.B. Gori: Leaf quality and usability -
theoretical model 1. Beitr. Tabakforschl., Vol. 8, 1975.
Patel, A.R. and G.B. Gori: Preparation and monitoring of
marijuana smoke condensate samples. Bull. Narc. 27:47, 1975.
Gori, G.B.: Artificial tobacco substitutes. J. Am. Med. Assoc.
234:489-490, 1975.
Gori, G.B. and J.A. Peters: Etiology and prevention of cancer.
Prev. Med. 4:239-246, 1975.
Gori, G.B.: Summary of the informal discussion of dietary
factors and cancer of the large bowel. Cancer Res. 35:3432-3436,
1975.
Gori, G.B.: The diet, nutrition, and cancer program of the NCI
National Cancer Program. Cancer Res. 35:3545-3547, 1975.
Gori, G.B. (Ed.) : Proceedings of the Tobacco Smoke Inhalation
Workshop on Experimental Methods in Smoking and Health Research.
DHEW Publication No. (NIH) 75-906, 84 pp.
Hoffman, D., C. Patriankos, K.D. Brunnemann and G.B. Gori:
Chromatographic determination of vinyl chloride in tobacco smoke.
Anal. Chem. 48:47-50, 1976.
Gori, G.B.: Approaches to the reduction of total particulate
matter (TPM) in cigarette smoke. In: Proceedings/3rd World
Conference on Smoking and Health - Modifying the Risk for the
Smoker. DHEW Publication No. (NIH) 76-1221, 1:451-461, 1976.
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION 14 TIMN 431092

Brunnemann, K.D., D. Hoffmann, E.L. Wynder and G.B. Gori: The
determination of tar, nicotine and carbon monoxide in cigarette
smoke: a comparison of international smoking conditions. In:
Proceedings. 3rd World Conference on Smoking and Health -
Modifying the Risk for the Smoker. DHEW Publication No. (NIH)
76-1221, 1:441-449, 1976.
Tso, T.C., G.B. Gori and D. Hoffmann: Reduction of nicotine and
tar in tobacco and cigarettes through agricultural techniques.
In: Proceedings/3rd World Conference on Smoking and Health -
Modifying the Risk for the Smoker. DHEW Publication No. (NIH)
76-1221, 1:35-48, 1976.
Gori, G.B., S.P. Battista, P.S. Thayer, M.R. Guerin and C.J.
Lynch: Chemistry and In Vitro Bioassay of Smoke from Experimental
Filter Cigarettes. DHEW Publication No. (NIH) 76-1076, 42 pp.
Gori, G.B. (Ed.) : Report No. 1 - Toward Less Hazardous
Cigarettes - The First Set of Experimental Cigarettes. DHEW
Publ ication No. (NIH) 76-905.
Gori, G.B. (Ed.) : Report No. 2 - Toward Less Hazardous
Cigarettes - The Second Set of Experimental Cigarettes. DHEW
Publication No. (NIH) 76-1111.
Gori, G.B.: Low risk cigarettes: a prescription. Science
194:1243-1246, 1976.
Scotto, J., T.R. Fears and G.B. Gori: Measurement of Ultraviolet
Radiation in the United States and Comparison with Skin Cancer
Data. DHEW Publication No. (NIH) 76-1029, 1976.
Gori, G.B.: Contributor in: Lung Cancer U.I.C.C. Technical
Report Series No. 25, Wynder and Hecht Eds., Geneva, Switzerland,
1977.
Wynder, E.L. and G.B. Gori: Contribution of the environment to
cancer incidence: an epidemiologic exercise. Journal of the
National Cancer Institute 58:825-832, 1977.
Tso, T.C. and G.B. Gori: A novel approach in tobacco production
as food source and smoke material - year 1976 to year 2000.
Proc. VI Intern. Tobacco Sci. Congress, Tokyo, Japan, pp. 81-86,
November 1976.
Gori, G.B. (Ed.) : Report No. 3 - Toward Less Hazardous
Cigarettes - The Third Set of Experimental Cigarettes. Number
(BIH) 77-120. GPO, Washington, DC, 1977.
15 TIMN 431093
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION

Gori, G.B.: Nutrition and cancer therapy. Cancer Research
37:2469-2471, 1977.
Gori, G.B.: Ranking of environmental contaminants for bioassay
priority. In Air Pollution and Cancer in Man. World Health
Organization. International Agency for Research on Cancer.
Publication 16, Lyon, France, pp. 99-111, 1977.
Gori, G.B.: Diet and cancer. Journal of American Dietetic
Association 17:375-379, 1977.
Gori, G.B. and B.J. Richter: The macroeconomics of disease
prevention in the United States. Science 200:1124-1130, 1978.
Gori, G.B. and C.J. Lynch: Toward less hazardous cigarettes.
JAMA 240:1255-1259, 1978.
Gori, G.B.: Role of diet and nutrition in cancer cause,
prevention and treatment. Bull. Cancer 65:115-126, 1978.
Gori, G.B.: Diet and nutrition in cancer causation. In Chemical
Toxicology of Food, C.L. Galli, R. Paoletti, and G. Vettorazzi,
Eds. Elsevier/North-Holland Biomedical Press, 1978.
Gori, G.B.: Diet and nutrition in cancer causation. Nutrition
and Cancer 1:507, 1978.
Gori, G.B. and R.L. Ellis: Reduction of carbon monoxide in
cigarette smoke. Prev. Med. 8:358-363, 1979.
Gori, G.B.: Summary of the workshop in carbon monoxide and
cardiovascular diseases. Prev. Med. 8:404-408, 1979.
Gori, G.B.: Dietary implications in the multifactorial etiology
of certain human cancers. Cancer 43:2151, 1979.
Gori, G.B.: Low risk cigarettes, letter to the editor. Science
204:690-692, 1979.
Gori, G.B. and C.J. Lynch: Development of less hazardous
cigarettes, letter to the editor. JAMA 241:2005, 1979.
Gori, G.B. and C.J. Lynch: Socially tolerable smoke, letter to
the editor. JAMA 241:2142, 1979.
Gori, G.B. and C.J. Lynch: Toward less hazardous cigarettes,
letter to the editor. JAMA 241:2143, 1979.
16 TIMN 431094
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION

Gori, G.B.: Food as a factor in the etiology of certain human
cancers. Food Technology 33:48-56, 1979.
Gori, G.B.: The regulation of carcinogenic hazards. Science
208:256-261, 1980.
Gori, G.B.: Observed no-effect thresholds and the definition of
less hazardous cigarettes. J. of Environmental Pathology and
Toxicology 3:193-203, 1980.
Miller, A.B. with the assistance of Gio B. Gori, et al.:
Nutrition and cancer. Prev. Med. 9:189-196, 1980.
Hoffmann, Dietrich, T.C. Tso and G.B. Gori: The less harmful
cigarette. Prev. Med. 9:287-296, 1980.
Weissburger, J., M.D. Hegsted, G.B. Gori and B. Lewis: Extending
the Prudent Diet to Cancer Prevention. Prev. Med. 3:297-304,
1980.
Gori, G.B.: Priorities in cancer prevention: a conference
appraisal. Prev. Med. 9:305-308, 1980.
Gori, Gio B. and Fred G. Boch, Eds.: The Banbury Report 3 - A
Saf e Cigarette? Cold Spring Harbor Laboratory, 1980.
Lynch, Cornelius J. and Gio B. Gori: Nondetectable risk levels
in cigarette smoking. In The Banbury Report, Cold Spring Harbor
Laboratory, 1980.
Gori, Gio B.: Less hazardous cigarettes: theory and practice.
In The Banbury Report, Cold Spring Harbor Laboratory, 1980.
Ritcher, Brian J. and Gio B. Gori: Demographic and economic
effects of the prevention of early mortality associated with
tobacco related diseases. In The Banbury Report, Cold Spring
Harbor Laboratory, 1980.
Gori, G.B. (Ed.) : Report No. 4 - Toward Less Hazardous
Cigarettes - The Fourth Set of Experimental Cigarettes. National
Cancer Institute, 1980.
Battista, S.P., P. Mione, A. Lappey and G.B. Gori: The role of
clotting factors in the etiology of lung disease related to
ciliostasis. Arch. of Envir. Health 35:239-246, 1980.
TIMN 431095
CONFIDENTIAL: 17
MINNESOTA TOBACCO LITIGATION

Gori, G.B.: Cancer prevention through prudent diet. In
Nutrition and Food Science, Vol. 3. W. Santos, N. Lopes, J.J.
Barbosa, D. Chaves, and J. C. Valente, Eds. Plenum Press, 1980.
Gori, G.B.: Carcinogens and regulation, letter to the editor.
Science 211:335, 1981.
Gori, G.B.: The cancer and other connections...if any. Nutrition
Today 16:14-22, 1981.
Gori, G.B.: The regulation of carcinogenic hazards. In Risk in
the Technological Society. C. Hohenemser and J.X. Kasperson,
Eds. AAAS Symposium Volume, 1981.
Gori, G.B.: The uncertain business of testing for cancer. The
Wall Street Journal, CXCVIII:32, 1981.
Gori, G.B.: Regulation of Cancer Causing Substances: Utopia or
Reality, Chemical Engineering News 60:(36):25-32, 1982.
Gori, G.B.: Smoker Intake from Cigarettes in the 1-mg Federal
Trade Commission Tar Class. Regulatory Toxicology and
Pharmacology 3:110-120, 1983.
Gori, G.B.: Cancer Hazards, Risks and Thresholds an Assessment.
In Cancer and the Environment. Possible Mechanism of Thresholds
for Carcinogens and Other Toxic Substances. (International
Center for Environmental Health Sciences, Inc. Ed.) New
York:Mary Ann Liebert, Inc., 1983.
Gori, G.B.: Dietary factors in carcinogenesis. In Research in
Food Science and Nutrition, Vol. 4. Food Science and Human
Welfare Series. J.V. McLoughlin and B.M. McKenna, Eds.
Proceedings of the Sixth International Congress on Food Science
and Technology, Dublin, Ireland, pp. 173-180, September 18-23,
1983.
Gori, G.B.: Ethylene dibromide: The regulation of prudence
(Editorial). Nutrition and Cancer 6:1-3, 1984.
Gori, G.B., B.J. Richter and W.-K. Yu: Economics of extended
longevity: a case study. Prev. Med. 13(4):396-410, 1984.
Gori, G.B. and C.J. Lynch: Analytical cigarette yields as
predictors of smoke bioavailability. Reg. Toxicol. Pharmacol.
5:314-326, 1985.
CONFIDENTIAL: 18 TIMN 431096
MINNESOTA TOBACCO LITIGATION

Gori, G.B. and C.J. Lynch: Decline of U.S. Cancer Mortality
Rates: Expert Estimates of Past Underreporting. Reg. Toxicol.
Pharmacol. 6:261-273, 1986.
Gori, G.B., N.L. Benowitz and C.J. Lynch: Mouth versus deep
airways absorption of nicotine in cigarette smokers. Pharmacol.
Biochem.& Behav.25:1181-1184, 1986.
Gori, G.B. Experimental atherogenesis - Effects of chronic
nicotine and carbon monoxide inhalation in Beagles. In
preparation.
Gori, G.B. Health and longevity policies: the case for
macroeconomic considerations. In preparation.
Gori, G.B. Smoker perception of FTC tar and nicotine yields
survey. In preparation.
Gori, G.B. Cigarette grading as a consumer message. In
preparation.
: a
Gori, G.B. Correlation of analytical yields for tar, nicotine
and carbon monoxide of U.S. filter cigarettes. In preparation.
Gori, G.B. The economic quantification of health and disease
values. In preparation.
Gori, G.B., Epidemiology and the concept of causation in
multifactorial diseases. Regul. Pharmacol. Toxicol. In press.
.
CONFIDENTIAL: 19 TIMN 431097
MINNESOTA TOBACCO LITIGATION

COMPANY AND CLASSIFIED PUBLICATIONS
Project Director and/or Senior Author in the following
Concentration and quantitation of viral infectivity in model food
samples. Melpar T/A 59128.701, 1965.
Six reports, Moloney Leukemia Virus Program. Melpar 5392.00200
(Ph43-65-1033), 1965-66.
The alteration of the indigenous microflora of the monkey.
Melpar T/A 68196.701, 1966.
Four reports, The antitumor activity of characterized bival ve
mollusk extracts. Melpar 5498.00100 (Ph43-66-35).
The preparation and testing of simian viruses and homologous
antisera. Melpar T/A 68673.706, 1966.
The preparation and testing of cell-associated "T" antigens of
viruses. Melpar T/A 68716.706, 1966.
Physiopathological monitoring of small primates. Melpar T/A
68712.706, 1966.
Oncogenicity of biological products in syrian hamsters. Melpar
T/A 68770.706, 1966.
A study to determine the potential carcinogenicity and toxicology
of seven chemically defined compounds. Melpar T/A 69439.762,
1966.
The simultaneous influence of magnetic fields and ionizing
radiation upon mammals or mammalian systems. Melpar T/A
69070.702, 1966.
The antiviral and antitumor activity of biologically active algal
extracts. Preparation and purification. Melpar T/A 69288.702,
1966.
C®NF'IIIENTIALo 20 V-IM-S 431098
MINNESOTA TOBACCO LITIGATION

Study for the determination of toxicological and carcinogenic
potentials of oil adjuvant preparations. Melpar T/A 69438.762,
1966.
Chronic toxicity of various classes of cancer chemotherapeutic
compounds. Melpar T/A 69479.702, 1966.
Design and management of animal isolation facilities. Melpar T/A
69541.702, 1966.
Improved diagnostic reagents for rhinoviruses. Melpar T/A
71025.702, 1966.
Physiochemical and toxicological characteristics of oil
adjuvants, Melpar T/A 71127.702, 1966.
An investigation in the fate of mineral oil adjuvants. Melpar
T/A 71231.702, 1966.
Improved diagnostic reagents for arboviruses. Melpar T/A
71314.702, 1967.
Oncogenic studies in tissue cultures and newborn animals. Melpar
T/A 71028.702 (Ph43-67-1100), 1967.
The toxic and potential carcinogenic mode of B-propiolactone.
Melpar T/A 71395.702, 1967.
Diagnostic methods for Rubella virus. Melpar T/A 71498.762,
1967.
Studies with Rubella virus and other viruses in primates and
small animals. Melpar T/A 69273.702 (Ph43-67-1184), 1967.
Opportunities in respiratory virus vaccine production. Litton
Systems, WSC-C-1020, 1967.
Production and testing of arbovirus reference reagents.
Systems, WSC-C-1016, 1967.
Litton
Manufacture of immunogenic polysaccharides. Litton Systems, WSC-
C-1014, 1967.
Storage of kidneys for transplantation. Litton Systems, WSC-C-
1011, 1967.
Radioimmune assays for FSH & LH in human serum. Litton Systems,
WSC-C-1010, 1967.
CONFIDENTIAL: 21 TIMN 431099
MINNESOTA TOBACCO LITIGATION

Analytic studies in air pollution. Litton Systems, WSC-C-1003,
1967.
Operation of a Rubella Service Laboratory. Litton Systems, WSC-
6004,1967.
Continuous monitoring of water pollutants. Litton Systems, WSC-
6007, 1967.
Analysis of pesticide residues. Litton Systems, WSC-6008, 1967.
Minimizing pesticide residue contaminants of crops. Litton
Systems, WSC-6010, 1967; Control system for stream and river
pollutants. Litton Systems, WSC-6011.
Soluble exotoxin of Vibrio Cholera. Litton Systems, WSC-6013,
1967.
Thyrocalcitonin & parathyroid hormone in blood samples. Litton
Systems, WSC-6016, 1967.
Chemistry of the hypothalamic releasing factor. Litton Systems,
WSC-6017, 1967.
Species differences in disposition of DDS and DADDS. Litton
Systems,- WSC-6024, 1967.
Lecithin synthesis in lungs. Litton Systems, WSC-6025, 1967.
Analyses of food samples. Litton Systems, WSC-6-26, 1967.
Diminution of pesticide residues for fish and wildlife programs.
Litton Systems, WSC-6032, 1967.
Enteric flora studies in man and rats. Litton Systems, WSC-6033,
1967.
An automatic diabetes screening device. Litton Systems, WSC-
6037, 1968.
Long term holding facilities for small animals. Litton Systems,
WSC-6039, 1968.
Effects of various materials on constituents of blood, Litton
Systems, WSC-6040, 1968.
22
CONFIDENTIAL:
MINNESOTA TOBACCO LITIGATION
TIMN 431100

Pharmacology and toxicology of LSD-25 derivatives. Litton
Systems, WSC-6041, 1968.
Materials for use in blood pumps and oxygenators. Litton
Systems, WSC-6045, 1968.
Cocarcinogenicity of cyclopropenoid compounds. Litton Systems,
WSC-6047, 1968.
Carcinogenicity of industrial pollutants and cigarette smoke.
Litton Systems, WSC-6049, 1968.
Toxicity and carcinogenicity of progestational drugs. Litton
Systems, WSC-8000, 1968.
Extracts of invertebrate tissue for antitumor screening. Litton
Systems, WSC-8001, 1968.
Carcinogenic potential of oral contraceptives. Litton Systems,
WSC-8002, 1968.
CONFIDENTIAL: 23 TIMN 431101
MINNESOTA TOBACCO LITIGATION
